The company’s success was greater than expected, said Stuart Essig, Integra’s CEO. The company reported a GAAP net income of $16.5 million, an increase from the third quarter of 2009.
Integra’s orthopedic business has earned $72,970 during the third quarter, a 13.8 percent increase over last year. The company’s neurosurgery business also experienced a 3.8 percent increase to $69,816.
Read the release on Integra LifeSciences 3Q FY 2010 financial report.
Read other coverage on Integra LifeSciences:
– Integra LifeSciences Annouces Milestone for Vu a-POD Device
– Integra LifeSciences Contracts With The Broadlane Group
– Integra LifeSciences to Feature Total Wrist Fusion System for Arthritis Treatment
